In a small retrospective single-center study that investigated patients with sepsis-induced DIC, gabexate mesilate as serine protease inhibitor versus recombinant thrombomodulin, thrombomodulin was found to be more effective in improving platelet counts, C-reactive protein (CRP) concentrations, and MOF [103]. This evidence concerns the gene CRP and Sepsis.